α1 - adrenoreceptors |
|
Epinephrine
Norepinephrine
Phenylephrine
Methoxamine
Midodrine
Oxymetazoline
|
|
Luo et al., 2016, Kim and Jwa, 2015, Manoharan et al., 2016, Hirst and Silinsky, 1975, Grayson and Oyebola, 1983
|
α2- adrenoreceptors |
N/A |
Epinephrine
Norepinephrine
Clonidine
Oxymetazoline
|
|
Shelkar et al., 2016 |
β1-adrenoreceptors |
|
Epinephrine
Norepinephrine
Isoprenaline
Dopamine
Dobutamine
|
|
Manivasagam et al., 2016, Grayson and Oyebola, 1983
|
β2-adrenoreceptors |
|
Epinephrine
Isoprenaline
Salbutamol
Albuterol
Terbutaline
Salmeterol
Formoterol
Pirbuterol
Albuterol
Mirabegron
|
|
Edgell et al., 2016, Arcaro et al., 2016, Cortese et al., 2016, Blais et al., 2016, Grayson and Oyebola, 1983
|
D1
|
|
|
|
Borcherding et al., 2015, Sclafani, 2001
|
D2
|
|
Dopamine
Aripiparazole
Quinpirole
Ketamine
Phencyclidine
Bromocriptine
|
|
##Ji and Wu, 2016, Jiang et al., 2016, Li et al., 2015, Lladó-Pelfort et al., 2016, Sclafani, 2001
|
D3
|
|
Dopamine
Quinpirole
Cariprazine
|
|
Watson et al., 2015, Sander et al., 2016, Sclafani, 2001
|
D4
|
|
|
|
Sclafani, 2001 |
D5
|
|
|
|
Sclafani, 2001 |
5 - HT1
|
|
|
|
Kishi et al., 2013, Araldi et al., 2016, Gershon et al., 1990
|
5-HT2
|
Trazadone
Atypical Antipsychotics
|
LSD (5-HT2A)
Lisuride (5-HT2A)
Mescaline (5-HT2A)
Lorcaserin (5-HT2C)
|
|
Karaki et al., 2014, Higgins et al., 2016, Gershon et al., 1990
|
5-HT3
|
• Ondansentron |
N/A |
|
Neal and Bornstein, 2006 |
5-HT4
|
N/A |
|
|
Lefebvre et al., 2016, Neal and Bornstein, 2006
|